Figure 1
From: The 2014 San Antonio Breast Cancer Symposium: A successful lift-off for breast immunotherapy?
Conceptualization of how multiple immunologic biomarkers could be used to personalize immunotherapy. CSF-1R, colony-stimulating factor 1 receptor; PD-1, programmed death 1; PD-L1, programmed death ligand 1; TILs, tumour-infiltrating lymphocytes.
